Enable Technologies

The main objective of our Technological Innovation Research Division is to develop new technical, computational and therapeutic procedures (chemical, biological, cellular, tissue), aimed at achieving a better understanding of the molecular basis of diseases, and a more appropriate therapeutic and clinical approach for each one of them.

The different projects carried out in the division focus on the search for therapeutic strategies based on the identification, by bioinformatics and experimental methods, of new biomarkers and therapeutic targets that, through the use of state-of-the-art technological and therapeutic procedures, make it possible to achieve new treatments for diseases for which there is a clear clinical need. This strategy includes approaches based on 3D design and printing, chemical synthesis of biomaterials, cellular reprogramming and stem cells, all with a clinical orientation.

The research carried out in the division, based on multidisciplinary programs and groups, has a clear innovative and translational vocation, and seeks to have an impact on the identification of the mechanisms involved in very diverse pathologies and their treatment. On the other hand, developments in the knowledge of tissues will allow progress in the development of human organs for therapeutic use.